Back | Next |
home / stock / ikt / ikt message board
Subject | By | Source | When |
---|---|---|---|
what do you make of this data? | jedijazz | investorshub | 04/05/2023 11:31:19 AM |
$IKT Thoughts on where this is headed? | conix | investorshub | 04/05/2023 11:11:24 AM |
what do you make of this data? | conix | investorshub | 04/05/2023 7:30:03 AM |
$IKT Do we have a winner?Turn around time? | ProfitScout | investorshub | 04/05/2023 5:13:16 AM |
Thoughts on where this is headed? | jedijazz | investorshub | 04/05/2023 1:56:09 AM |
$IKT Have a look at this | conix | investorshub | 04/05/2023 1:26:17 AM |
Price trading | conix | investorshub | 04/04/2023 9:05:41 PM |
MomentumIts gaining | conix | investorshub | 04/04/2023 8:51:49 PM |
$IKT The trading | TrendTrade2016 | investorshub | 04/04/2023 3:45:06 PM |
Price trading | budfoxfun | investorshub | 04/04/2023 2:26:17 PM |
bulls and bears | conix | investorshub | 04/04/2023 2:10:01 PM |
$IKT Have a look at this | conix | investorshub | 04/04/2023 2:02:35 PM |
$IKT good read | conix | investorshub | 04/04/2023 12:42:07 PM |
$IKT The trading last up | conix | investorshub | 04/04/2023 10:44:11 AM |
$IKT short squeeze all day | conix | investorshub | 04/04/2023 5:36:21 AM |
MomentumIts now | conix | investorshub | 04/04/2023 1:39:24 AM |
Price trading up | conix | investorshub | 04/04/2023 12:26:01 AM |
$IKT bears are running | conix | investorshub | 04/03/2023 6:27:50 PM |
$IKT MomentumIts gaining last up | conix | investorshub | 04/03/2023 12:19:15 PM |
$IKT what do you make of this data? | conix | investorshub | 04/03/2023 7:48:05 AM |
News, Short Squeeze, Breakout and More Instantly...
Inhibikase Therapeutics Inc. Company Name:
IKT Stock Symbol:
NASDAQ Market:
Inhibikase Therapeutics Inc. Website:
BOSTON and ATLANTA, June 17, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease, Parkinso...
- Company positioning multiple assets for late-stage development across its therapeutic pipeline – BOSTON and ATLANTA, June 05, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage pharmaceutical company developing protein kin...
BOSTON and ATLANTA, May 20, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease, Parkinson...